Furthermore, along with chemotherapy, targeted therapies such as monoclonal antibodies targeting epidermal growth factor receptor (EGFR) (e.g., cetuximab) and vascular endothelial growth factor (VEGF) (e.g., bevacizumab) are the gold standard treatments for advanced or metastatic colorectal cancer. Here, EGFR is linked to metastatic colorectal cancer.